APA

Kageyama S., Weinstein J. N., Shirasaka T., Kempf D. J., Norbeck D. W., Plattner J. J., Erickson J. & Mitsuya H. (19920922). In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations. : Antimicrobial agents and chemotherapy.

Chicago

Kageyama S, Weinstein J N, Shirasaka T, Kempf D J, Norbeck D W, Plattner J J, Erickson J and Mitsuya H. 19920922. In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations. : Antimicrobial agents and chemotherapy.

Harvard

Kageyama S., Weinstein J. N., Shirasaka T., Kempf D. J., Norbeck D. W., Plattner J. J., Erickson J. and Mitsuya H. (19920922). In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations. : Antimicrobial agents and chemotherapy.

MLA

Kageyama S, Weinstein J N, Shirasaka T, Kempf D J, Norbeck D W, Plattner J J, Erickson J and Mitsuya H. In vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations. : Antimicrobial agents and chemotherapy. 19920922.